2018 Opioid Epidemic Forum Agenda

 

Agenda

Day One, July 16, 2018

 

7:15am – 8:00am

Conference Registration & Networking Breakfast

 

8:00am – 8:15am

Chairperson’s Remarks

 

8:15am – 9:00am

How Pharmacists Can Lead an Opioid Exit Plan

Managing postoperative pain while providing patient education is essential to fighting the opioid epidemic. As medication experts, pharmacists are key personnel in identifying non-opioid analgesic regimens for patients. This session will cover the role of pharmacists in managing acute pain in postoperative patients. Topics to be discussed will include:
-       The role of pharmacists in developing and implementing opioid-sparing postoperative analgesic regimens
-       Approaches to managing postoperative pain in patients with a history of opioid use disorder
-       Planning appropriate analgesic regimens for hospital discharge, including identification of high-risk patients
-       Strategies for effective patient counseling

 

Douglas R. Oyler, PharmD, BCCCP

Director

Office of Opioid Safety

Assistant Professor, Adjunct- College of Pharmacy

University of Kentucky HealthCare

 

9:00am – 9:45am

Battling the Opioid Epidemic with Clinical Communities: A Health System’s Approach to Opioid Stewardship

Based on CDC data, more than 45,000 people died from opioid overdose in the past 12 months. Healthcare systems, which integrate networks of hospitals, clinics, and emergency rooms, have the capacity to change the landscape in terms of opioid prescribing and overdose deaths.  The Johns Hopkins Health System Opioid Stewardship Clinical Community was formed to implement best practices and generate solutions backed by science to address the opioid epidemic, with four key areas to target for intervention:
-       Decreasing excess exposure to opioids through judicious opioid prescribing
-       Educating of patients, clinicians, and others in the health system
-       Implementing quality metrics and analytics
-       Advocating for policies and regulation in support of opioid stewardship

 

Through the work of the clinical community, Johns Hopkins has improved the safety of opioid prescribing, standardized practices via electronic health record and order entry systems, and deployed evidence-based education to patients and providers.

 

Mark Bicket, MD

Director, Pain Medicine Fellowship Program

Assistant Professor

Johns Hopkins University School of Medicine

 

9:45am – 10:15am

Morning Networking & Refreshments Break

 

10:15am – 11:00am

How the Substance Abuse and Mental Health Services Administration (SAMHSA) is Responding to the Opioid Epidemic

With the opioid addiction problem in the United States continuing to rise, it is important for prescribers to educate themselves in substance abuse prevention. This session will discuss how health providers can use specific strategies to help reduce drug addiction. Strategies covered will include:
-       Using Prescription Drub Monitoring Programs (PDMPs) as patient safety tools
-       Screening, Brief Intervention and Referral to Treatment (SBIRT)
-       Establishing referral relationships with addiction treatment providers and social services programs in the community
-       Overcoming barriers to incorporating screening for addiction problems

 

Anthony Campbell, RPH, DO, FACP, CDR, USP

Medical Officer

Center for Substance Abuse Treatment

Division of Pharmacologic Therapies

Substance Abuse and Mental Health Service

Administration (SAMHSA)

 

 

11:00am – 11:45am

It Takes a Village: Tackling the Opioid Epidemic from Multiple Angles

Current efforts to stop the opioid epidemic continue to fail. The healthcare community is uniquely situated to stop the misuse and abuse of controlled substances through education, prevention, and treatment. States that have mandated prescriber checks of prescription drug monitoring databases (PDMP/PMP) together with electronic prescribing of controlled substances (EPCS) have seen dramatic decreases in opioid prescribing. But more needs to be done. While each US state has a PDMP database, requirements for use vary. Still, this rich source of data will help us attack the opioid crisis from all angles.

 

Linda Fischer

Vice President, Product Strategy

DrFirst

 

11:45am – 12:45pm

Lunch

 

12:45pm – 1:30pm

How Pharmacy Benefit Managers (PBMs) and Pharmacists Can Manage Opioid Prescribing

This session will embark on how PBMs can help to reduce the overprescribing and misuse of opioid medications. This program will cover the following:
-       How to evaluate opioid utilization data and leverage enhanced utilization management strategies to reinforce prescribing best practices and dispensing guidelines
-       “Red flags” to alert dispensing pharmacists of potential opioid overuse/abuse
-       Non-compliance due to repeated attempts of early refills
-       Locking a patient into using a single opioid prescriber/pharmacy when system shows multiple prescribing physicians prescribing the same drug
-       Academic detailing approaches to collaboratively partner with prescribers on safe opioid dose titration and patient support strategies
-       Facilitating safe opioid storage and disposal
-       Improving access to and education on the importance and proper usage of naloxone
-       Leveraging digital solutions to improve pain management and patient support

 

Steve Cutts, PharmD, Rph

Vice President, Pharmacy Services

and Clinical Strategy

Magellan Rx

 

  

1:30pm – 2:15pm

CDC Perspective – A Public Health Approach to Opioid Overdose Prevention

This session will discuss the public health approach to opioid overdose prevention as advanced by the Centers for Disease Control and Prevention.  CDC’s efforts are designed to improve data quality and timeliness to better track trends, identify communities at risk, and evaluate prevention strategies; to strengthen state efforts by scaling up effective interventions, particularly those at the community or systems level; and to equip health care providers with the data and tools they need to improve opioid prescribing and improve patient safety. CDC’s Overdose Prevention in States (OPIS) funds state health departments to advance surveillance innovations and to implement and evaluate prevention efforts; examples from these programs will be highlighted.  In addition, the clinical support and resources for the CDC Guideline for Prescribing Opioids for Chronic Pain will be shared, with insights from successful uptake of the Guideline.

 

 

Sarah Bacon, PhD

Lead Behavioral Scientist

Prescription Drug Overdose State Support Team

Division of Unintentional Injury Prevention

Center for Disease Control and Prevention

 

2:15pm – 2:45pm

Afternoon Networking & Refreshments Break

 

2:45pm – 3:45pm

Panel: Implementing Strategies to Prevent Opioid Abuse - Building an Effective Continuum of Care for Opioid Use Disorder

Opioid use disorder is a chronic illness which can have remissions over time. To prevent readmissions related to this disorder, health systems need to apply the well-known concept of continuum of care for the management of opioid use disorder. There are many deficiencies of acute and long-term treatment and recovery support for patients dealing with substance abuse disorders. This session will discuss the following:
-       State programs that introduce recovery coaches in the ER
-       Expansion of Medication Assisted Treatment (MAT) with individual providers and clinics
-       Introducing Project ECHO in support of Opioid treatment
-       Describe how to implement these practices across your health system
-       Define prevention, treatment and recovery within the continuum of care model
-       Provide examples of how strategies are being applied for each of these components

 

Daniel Schwarz, MD, ABAM, FASAM

CLIA High Complexity Toxicologist

Principle/Director

The Center for Pain Recovery, MI

Chief Medical Officer

Full Circle to Completion, OH

Brian G. Swift, PharmD, MBA

Enterprise Vice President, Chief Pharmacy Officer

Jefferson Health

Associate Dean of Professional Affairs

Jefferson College of Pharmacy

Theodore A. Christopher, MD, FACEP

Chair, Department of Emergency Medicine

Thomas Jefferson University Hospital

 

Elizabeth Collier, MSW, CSAC, ICS, LCSW

State Opioid Treatment Authority

Division of Care and Treatment Services

Bureau of Prevention Treatment and Recovery

Wisconsin Department of Health Services

 

3:45pm – 4:30pm

Five Stages to Discontinuing Opioids: Conversations to De-escalate, Discontinue or Deprescribe Opioids for Chronic Pain

This session focuses on how to have the difficult conversation when opioids are no longer an option for chronic pain. Objectives include opioid de-escalation, post-opioid management, and non-opioid treatment options for patients suffering adverse effects, displaying aberrant behavior, or failing to meet therapeutic goals. This educational workshop and tool was mirrored after literature on grief and CDC clinical guidelines to aid in understanding emotional processing as patients ‘grieve’ changes in treatment. Clinicians will be instructed on a successful approach for the aforementioned treatment hurdles.

 

Kevin W. Chamberlin, PharmD, FASCP

Associate Clinical Professor & Assistant

Department Head, Pharmacy Practice, Residency

Program Director

University of Connecticut School of Pharmacy,

UConn Health

 

Rebecca Andrews, MS, MD FACP

Director of Ambulatory Education

Associate Program Director, Internal Medicine Residency

Associate Professor of Medicine

CT Institute of Primary Care Innovation

 

4:30pm – 5:15pm

How Hospitals are Fighting on the Frontlines of the Opioid Crisis

No health system is impervious to the effects of the opioid epidemic raging across the country.  With opioid deaths increasing on a daily basis, the epidemic is clearly worsening.  As such, the health care field is working to reverse the trend and raise awareness of the problem.  Our speakers will discuss the ways hospitals are combating this crisis.  Topics include forming a task force, identifying novel and best practices for prescribing and managing opioids, engaging administrative leaders and physicians, accessing community partners and resources, and collaborating with other hospitals and health systems.

 

Brian G. Swift, PharmD, MBA

Enterprise Vice President, Chief Pharmacy Officer

Jefferson Health

Associate Dean of Professional Affairs

Jefferson College of Pharmacy

Theodore A. Christopher, MD, FACEP

Chair, Department of Emergency Medicine

Thomas Jefferson University Hospital

 

 

5:30pm

Cocktail Reception

 


Day Two, July 17, 2018

 

7:15am – 8:00am

Networking Breakfast

 

8:00am – 8:15am

Chairperson’s Remarks

 

8:15am – 9:00am

Effectiveness of Opioid Use Guidelines in the Emergency Department

Prescription opioid abuse has become a leading cause of morbidity and mortality in the United States. This rise parallels a similar increase in the rate of opioid prescribing that quadrupled between 1990 and 2010. While most opioid prescriptions are from the ambulatory setting, the Emergency Department (ED) also plays a significant role as these patients often seen care in the ED. Over the past few years, strategies have been employed by public health groups and healthcare organizations to combat this crisis. The most commonly used approach is opioid prescribing guidelines that promote judicious opioid use. Critics have argued about the efficacy of these guidelines and raised concern about the potential for under-treating acute and severe pain. In this session, you will learn about the effectiveness of these methods to reduce opioid prescribing in the ED, as well as the pitfalls of current strategies and future direction for optimizing management of acute and chronic pain in the ED setting.

 

Ali Ghobadi, MD

Assistant Chief, Emergency Department

Kaiser Permanente - Orange County

Faculty- Loyola Marymount University,

Healthcare Systems Engineering

 

9:00am – 9:45am

Reducing the Opioid Addiction Through Health Registries and Electronic Health Records

Surgery is common and appropriate postoperative pain management is critical, as poor management can impair recovery and lead to adverse events including prolonged opioid use and transition to chronic pain. Although pain scores are routinely collected in electronic health records (EHRs), shared algorithms to utilize them for care improvement are limited. One roadblock is that postoperative pain and its related outcomes are complex. The gathering of evidence from EHRs, which draw from and inform real-world practice, help bypass this roadblock and inform decisions that lead to effective and efficient postoperative pain management. Such research enables pain measurement and its management possible across multiple populations and settings, which can provide critical evidence to stakeholders that could move the field away from pain treatment for the ‘average’ patient to pain treatment for an individual. Here we report on evidence from real world data on post-operative pain management in the era of the opioid epidemic.  We present information on opioid prescribing guideline adherence from 2 healthcare settings and present opioid alternatives that offer equivalent pain management. Pain is a common side-effect after any surgical procedure and new evidence highlights the magnitude of the opioid epidemic and suggests prescription opioids contribute significantly to this public health problem. In conclusion, while opioids are an easy way to manage postoperative pain, they may not be the best treatment for all patients.

 

Tina Hernandez-Boussard

Associate Professor of Medicine, Biomedical Data

Science, and Surgery

Stanford School of Medicine

 

 

 

9:45am – 10:15am

Morning Networking & Refreshments Break

 

10:15am – 11:00am

Facing the Opioid Epidemic in Health Care: Culture Building

Close to 80% of heroin addicts started their addiction with prescription Opioids. Large Integrated Healthcare Networks have the capacity to change the landscape in terms of opioid prescribing and consequently overdose deaths. This session will focus on:
-       A unified message of adherence to evidence-based pain management builds a Culture
-       Safe opioid medication prescribing
-       Use of innovative technologies such (SCAN-ECHO) to disseminate Best Practices

 

Ali Mchaourab, MD

Associate Professor of Anesthesiology

Case Western Reserve University

Chief, Pain Medicine Service

Director, Cleveland Specialty Care Access

Network (SCAN-ECHO)

Cleveland VA Medical Center

 

 

11:00am – 11:45am

Taking Advantage of the Mind’s Healing Abilities: Using Psychotherapy as an Alternative to Opiates for Chronic Pain

With the ever-increasing opioid epidemic, it is important to assess alternative methods for the treatment of pain. The examination of chronic pain from a biopsychosocial model is an example. Through this presentation, participants will understand the importance that psychotherapy, especially cognitive behavioral therapy (CBT) and mindfulness-based stress reduction (MBSR), can play in the treatment of acute and chronic pain.

 

Participants will gain an understanding of:
-       An orientation to cognitive behavioral therapy- a systematic, goal-oriented approach to understanding how thoughts and emotions affect physical pain
-       A structure of treatment using cognitive behavioral therapy for chronic pain
-       An introduction and application of mindfulness-based stress reduction therapy- a therapy based on the combination of relaxation and focusing on the present moment without judgement
-       And finding the connection between mindfulness and chronic pain and how mindfulness can provide a more accurate perception of pain intensity/frequency

 

It is imperative that clinicians and administrators continue to integrate effective psychotherapy techniques into medical settings, so we can treat those suffering from chronic pain without the added risks associated with opiate overuse. It is important to assess ways in which collaboration can benefit clients who are seeking treatment for pain as well as social services program.

Phillip West, MSW, LGSW, CTT

Clinical Therapist - Department of Behavioral

Medicine and Psychiatry

West Virginia University

Brittany Walters, MA, LPC, NCC

Clinical Therapist - Department of Behavioral

Medicine and Psychiatry

West Virginia University

 

11:45am – 12:30pm

Dealing with Opioid Addiction in Women of Childbearing Age and Newborn Infants

The opioid epidemic is growing across the US and includes a shift from prescription opioids to heroin among both men and women. Women with opioid addiction who become pregnant put their babies at risk of withdrawal after birth, but optimum therapy for the mother also uses opioid medication. Babies exposed to opioid medication in utero may develop neonatal abstinence syndrome (NAS) and require postnatal monitoring and therapy. This leads to a prolonged hospital stay for the baby, limiting the number of available neonatal intensive care beds for other babies and costing more than $1.5 billion. Strategies for identification and treatment of opioid addicted mothers and their babies with NAS are becoming a center of focus locally, with statewide collaboratives and with national organizations such as Center for Disease Control (CDC).
-       How did we get here?
-       1990s - Joint Commission pushed for consistent and increased measures to control patient’s pain due to the impact on overall health and recovery
-       Drugs that had been developed for severe pain associated with cancer – the opioids – were now being prescribed for any and all pain
-       Pharmaceutical companies downplayed the addictive nature of the opioids
-       No tracking of prescriptions to limit “shopping”
-       In the US, enough opioid prescriptions are written annually for every adult to have 1 bottle.
-       5% of the world’s population accounts for 80% of the world’s opioid prescriptions
-       Heroin epidemic is growing across the US and around the world
-       Prescription opioids are harder to get and are therefore becoming more expensive
-       Heroin is now relatively cheaper
-       Fentanyl is being added to heroin – “China White” – to increase its addictive power
-       Pregnant women continue to get opioid prescriptions during pregnancy
-       States with the highest numbers of opioid prescriptions given to pregnant women have the highest rates of NAS
-       Maternal addiction is usually managed medically using opioid drugs that can lead to NAS in the infant
-       Maternal opioid use and neonatal abstinence syndrome (NAS) in infants continue to increase
-       Mean hospital charges over $66,000 for NAS by 2012
-       Aggregate national hospital charges over $1.4 billion by 2012
-       Medicaid covers the bulk of the cost
-       More beds in Neonatal Intensive Care Units (NICUs) are being devoted to treating babies with NAS
-       Average therapy requires ~ 3 weeks in the NICU, limiting bed space for infants with other problems
-       This drives innovations to find alternative ways and locations for treating the infants
-       Strategies for identification of opioid addicted mothers and treatment of their babies with NAS are becoming a center of focus nationally
-       National organizations such as Center for Disease Control (CDC) and Vermont Oxford Network (VON) are offering collaborative initiatives
-       State perinatal collaboratives are focusing on standardizing programs across individual hospitals

 

Douglas E. Hardy, MD

Clinical Director, Level 3 NICU

Winnie Palmer Hospital for Women

& Babies

 

12:30pm

Conference Concludes

 

Register Now